Jump Financial’s PAVmed PAVM Stock Holding History

Jump Financial’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-234	Closed	-$259K	–	1816
2021 Q4	$259K	Buy	+234	New	+$509K	0.02%	961
2021 Q3	–	Sell	-81	Closed	-$233K	–	1398
2021 Q2	$233K	Buy	+81	New	+$191K	0.02%	781

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's PAVM Position: Q1 2022 in Review

Jump Financial sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 234 shares — an estimated $259K sold.

Jump Financial first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $259K in Q4 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

Jump Financial reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
Jump Financial sold 234 PAVmed shares in Q1 2022, an estimated $259K.
Jump Financial first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
Jump Financial's PAVmed position peaked at $259K in Q4 2021.
94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Jump Financial's 13F filing for Q1 2022, filed 12 May 2022.